Global Mebendazole Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Mebendazole Market Research Report 2024
Mebendazole (MBZ) is a medication used to treat a number of parasitic worm infestations. This includes ascariasis, pinworm disease, hookworm infections, guinea worm infections, hydatid disease, and giardia, among others. It is taken by mouth. Mebendazole is usually well tolerated.
According to Mr Accuracy reports’s new survey, global Mebendazole market is projected to reach US$ 173 million in 2034, increasing from US$ 117.6 million in 2024, with the CAGR of 5.6% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mebendazole market research.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mebendazole market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Segment by Type
Tablet
Oral Suspension
Below 2 Years Old
Above 2 Years Old
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mebendazole report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Mebendazole market is projected to reach US$ 173 million in 2034, increasing from US$ 117.6 million in 2024, with the CAGR of 5.6% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Mebendazole market research.
The classification of Mebendazole includes Tablet and Oral Suspension. The proportion of Tablet in 2019 is about 86%.
Mebendazole is widely used for <2 Years Old and >=2 Years Old. The most proportion of Mebendazole used for >=2 Years Old, and the proportion in 2019 is about 74%.
Asia Pacific is the largest market, with a sales market share nearly 35% in 2019. Following Asia Pacific, North America is the second largest sales place with the sales market share of about 21%.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Mebendazole market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Tenry
Segment by Type
Tablet
Oral Suspension
Segment by Application
Below 2 Years Old
Above 2 Years Old
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Mebendazole report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source